Increase In Startle Response Research Articles

Cell‐type specific expression of GluN2C and GluN2D subunits and their role in schizophrenic phenotypes

IntroductionFunctional deficit in NMDA‐receptors on parvalbumin (PV)‐positive interneurons (PV‐NMDARs) is central to the pathophysiology of schizophrenia. NMDA channel blockers like ketamine and MK‐801 have shown to produce psychosis by inhibiting GluN2C and GluN2D subunits with greater affinity than other subunits. Recent neuroanatomical and electrophysiological studies have reported expression of GluN2D subunit in PV positive interneurons in corticolimbic regions but the precise distribution of GluN2C subunit especially in PV interneurons remains unknown.Hence, the objective of the study was to identify the expression pattern of GluN2C subunit in neuronal and non‐neuronal cell population and to perform a side‐by‐side comparison of the effect of partial and complete ablation of GluN2C and GluN2D subunit on pure C57BL/6N mouse strain.Methods and ResultsImmunohistochemistry was used to determine the heterogenous expression of GluN2C using a novel eGFP reporter mouse model. We found the expression of EGFP (GluN2C) with PV positive neurons in nucleus reticularis of the thalamus, globus pallidus externa and interna, ventral pallidum and substantia nigra. Interestingly, EGFP (GluN2C) showed co‐localization with astrocytic marker in the striatum, cortex, hippocampus and amygdala but not with PV positive neurons. GluN2C was found to be enriched in several thalamic relay nuclei including first order and higher order nuclei. GluN2D knockout mouse exhibited hypo‐locomotion and anxiety‐like behavior in the open field test. We found a significant increase in startle amplitude in GluN2C HET but not GluN2C KO and no change in prepulse inhibition (PPI) in either genotype was observed. Increase in startle response was found for GluN2D heterozygous and GluN2D knockout along with lower prepulse inhibition at some decibels. We also found CIQ, a selective positive allosteric modulator for GluN2C/GluN2D subunit, reversed the MK801 induced impairment in PPI in GluN2C wildtype and heterozygous mice but not in GluN2C KO mice. Furthermore, we observed that GluN2C knockout mice but not GluN2D knockout mice were less sensitive to phencyclidine‐induced hyperlocomotion, a model of psychosis. The cell‐type specific expression of both GluN2C and GluN2D subunit may provide more insights into schizophrenia‐like behaviors. Hence, we will confirm psychotic and sensorimotor deficits by selectively deleting GluN2D subunit from PV‐positive interneurons and GluN2C subunit from astrocytes using Cre‐lox strategy.ConclusionTogether, these results identify the unique expression pattern of GluN2C subunit in neuronal and non‐neuronal cell population. It also demonstrates the preferential involvement of GluN2C‐ containing receptors in phencyclidine‐induced hyperlocomotion and that facilitation of GluN2C subunit may reverse the schizophrenic phenotypes.Support or Funding InformationR21 NS104705This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Empirically based comparisons of the reliability and validity of common quantification approaches for eyeblink startle potentiation in humans.

Startle potentiation is a well‐validated translational measure of negative affect. Startle potentiation is widely used in clinical and affective science, and there are multiple approaches for its quantification. The three most commonly used approaches quantify startle potentiation as the increase in startle response from a neutral to threat condition based on (1) raw potentiation, (2) standardized potentiation, or (3) percent‐change potentiation. These three quantification approaches may yield qualitatively different conclusions about effects of independent variables (IVs) on affect when within‐ or between‐group differences exist for startle response in the neutral condition. Accordingly, we directly compared these quantification approaches in a shock‐threat task using four IVs known to influence startle response in the no‐threat condition: probe intensity, time (i.e., habituation), alcohol administration, and individual differences in general startle reactivity measured at baseline. We confirmed the expected effects of time, alcohol, and general startle reactivity on affect using self‐reported fear/anxiety as a criterion. The percent‐change approach displayed apparent artifact across all four IVs, which raises substantial concerns about its validity. Both raw and standardized potentiation approaches were stable across probe intensity and time, which supports their validity. However, only raw potentiation displayed effects that were consistent with a priori specifications and/or the self‐report criterion for the effects of alcohol and general startle reactivity. Supplemental analyses of reliability and validity for each approach provided additional evidence in support of raw potentiation.

Amygdala Activity, Fear, and Anxiety: Modulation by Stress

Amygdala Activity, Fear, and Anxiety: Modulation by Stress

Modification of Acoustic Startle Reactivity by Cocaine Administration During the Postnatal Period: Comparison With a Specific Serotonin Reuptake Inhibitor

This study investigated whether exposure to cocaine during the postnatal period affects the acoustic startle response (ASR) following administration of the serotonin (5-HT) agonists, 8-OH-DPAT and mCPP , in adulthood. To test the hypothesis that alterations in reactivity may be due to cocaine's effects at the 5-HT carrier, another group of rats was given fluoxetine, a specific 5-HT uptake inhibitor, during the same postnatal period and tested along with the cocaine-treated rats. Male and female rats received 25 mg/kg/day cocaine HCl, fluoxetine HCl, or vehicle SC during postnatal days 11–20. At 75 days of age, subjects were ASR tested for 30 min on 2 consecutive days. On the first test day, there was a significant effect of treatment and gender with post hoc analysis indicating that, overall, the males were more reactive than the females and that the fluoxetine-treated males showed a pattern of reactivity resembling sensitization. On the second test day, subjects received a dose of the 5-HT 1A agonist 8-OH-DPAT, the 5- HT 1 B 2 C agonist, mCPP , or saline prior to being placed in the startle chamber. Cocaine-exposed males showed an enhanced response to 8-OH-DPAT and a reduction in the depression produced by mCPP administration compared to their response to saline. Fluoxetine exposed males showed a significant increase in startle response following saline administration compared to the rats receiving vehicle during the postnatal period and 8-OH-DPAT produced an insignificant enhancement of that startle response. mCPP reduced startle in fluoxetine-treated males as it did in the postnatal vehicle-treated controls. In females, the postnatal cocaine and fluoxetine treatments did not alter the response to 8-OH-DPAT or mCPP compared to females receiving vehicle during the postnatal period. Together these data indicate that, in males, whereas postnatal cocaine alters the development of the 5-HT system as evidenced by an altered startle response to 5-HT agonists, cocaine does not produce the same alteration as that produced by the administration of a specific 5-HT uptake inhibitor during the same period of development.

Modification of acoustic startle reactivity by cocaine administration during the postnatal period: Comparison with a specific serotonin reuptake inhibitor

This study investigated whether exposure to cocaine during the postnatal period affects the acoustic startle response (ASR) following administration of the serotonin (5-HT) agonists, 8-OH-DPAT and mCPP, in adulthood. To test the hypothesis that alterations in reactivity may be due to cocaine's effects at the 5-HT carrier, another group of rats was given fluoxetine, a specific 5-HT uptake inhibitor, during the same postnatal period and tested along with the cocaine-treated rats. Male and female rats received 25 mg/kg/day cocaine HCl, fluoxetine HCl, or vehicle SC during postnatal days 11–20. At 75 days of age, subjects were ASR tested for 30 min on 2 consecutive days. On the first test day, there was a significant effect of treatment and gender with post hoc analysis indicating that, overall, the males were more reactive than the females and that the fluoxetine-treated males showed a pattern of reactivity resembling sensitization. On the second test day, subjects received a dose of the 5-HT 1A agonist 8-OH-DPAT, the 5- HT 1 B 2 C agonist, mCPP, or saline prior to being placed in the startle chamber. Cocaine-exposed males showed an enhanced response to 8-OH-DPAT and a reduction in the depression produced by mCPP administration compared to their response to saline. Fluoxetine exposed males showed a significant increase in startle response following saline administration compared to the rats receiving vehicle during the postnatal period and 8-OH-DPAT produced an insignificant enhancement of that startle response. mCPP reduced startle in fluoxetine-treated males as it did in the postnatal vehicle-treated controls. In females, the postnatal cocaine and fluoxetine treatments did not alter the response to 8-OH-DPAT or mCPP compared to females receiving vehicle during the postnatal period. Together these data indicate that, in males, whereas postnatal cocaine alters the development of the 5-HT system as evidenced by an altered startle response to 5-HT agonists, cocaine does not produce the same alteration as that produced by the administration of a specific 5-HT uptake inhibitor during the same period of development.

An increase in startle response in rats administered oxytocin

Twenty-four male albino Wistar rats were allocated to four groups and given either 23.2, 11.6 or 5.8 IU OXT/kg or vehicle (0.9% saline). A significant increase in startle response was observed in the 11.6 and 5.8 IU OXT/kg groups when compared to vehicle. Our results further support the suggestion that OXT is a “stress hormone” by implicating this peptide with increased emotionality/reactivity during a stressful experience.